Alternatives to Network Bio
Network Bio is a Biotechnology tool: leveraging AI and a massive patient tissue dataset to accelerate drug discovery and advance precision medicine. Here are the 60 closest alternatives, compared on pricing, features and what real users say.
The 20 closest Biotechnology companies to Network Bio
- Website
LifeMine Therapeutics Inc.60BiotechnologyWatertown, United States$543.0MClinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.
- Website
Infinimmune60BiotechnologyAlameda, United States$75.0MDeveloping human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.
- Website
Freenome59BiotechnologySouth San Francisco, USA$570.0MFreenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.
- Website
4D Path59BiotechnologyNewton, USA$17.4MPersonalizing cancer care through a novel, physics-informed approach to predict tumor response to therapy.
- Website
Arc Institute56BiotechnologyPalo Alto, United States$650.0MA nonprofit research organization leveraging AI and biotechnology to understand and treat complex diseases.
- EAEarendil Labs56BiotechnologyBeijing, China$787.0M
Earendil Labs is an AI biotechnology company focused on leveraging artificial intelligence for drug discovery and development of next-generation biologics.
- Website
Transcripta Bio54BiotechnologyPalo Alto, United States$24.0MAI-powered drug discovery company focused on neurological and neuromuscular diseases, leveraging transcriptomics to accelerate therapeutic development.
- Website
Waypoint Bio53BiotechnologyNew York, USA$20.0MAI-native biotech company designing next-generation CAR T therapies for solid tumors.
- Website KHKhartis Therapeutics, Inc.53BiotechnologySan Diego, United States$50.0M
Developing oral small molecule medicines for immunological and chronic diseases.
- Website
ParcelBio52BiotechnologySan Francisco, USA$100.0MAdvancing next-generation mRNA medicines.
- Website
Immitra Bio48BiotechnologyZürich, Switzerland$2.6MScalable, one-time curative in-vivo gene editing therapies.
- Website
IMU Biosciences47BiotechnologyLondon, United Kingdom$53.0MDecoding the immune system to pioneer a paradigm shift in disease diagnosis and treatment.
- Website TOTolemy Bio46BiotechnologyCambridge, United Kingdom$1.4M
AI-enabled technology for cell biology research and biopharma development.
- Website
Exobiosphere45BiotechnologyEsch-sur-Alzette, Luxembourg$3.2MSpace BioTech startup developing an autonomous, high-throughput screening platform for drug discovery in microgravity.
- Website
Graph Therapeutics44BiotechnologyBoston, Austria$5.0MDeveloping precision medicines for inflammatory and immune-mediated diseases using AI and patient sample analysis.
- Website
Houdini Bio42BiotechnologyCambridge, United Kingdom$1.7MEngineering-driven DNA design platform to overcome biological barriers in genetic medicines.
- Website
Virchow Medical41BiotechnologyLa Jolla, USA$4.0MAdvancing biopsy specimen stewardship and expanding access to precision oncology.
- Website
InduPro, Inc.39BiotechnologySeattle, United States$77.0MBiotechnology company defining membrane protein spatial relationships to create novel therapeutics for cancer and autoimmune diseases.
- Website
Moderna77BiotechnologyCambridge, United States$4.5BModerna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
- Website AVAvant Genomics34BiotechnologyCharlottesville, USA$3.0M
Developing an automated platform for liquid biopsy sample preparation.
Showing the 20 closest matches. See the rest on the Network Bio profile.
Compare Network Bio head to head
Side by side on what each one does, what it costs, and what real users report.